Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Syota Kagawa"'
Autor:
Syota Kagawa, Katsuya Tanabe, Makoto Hiromura, Kakuyou Ogawa, Takayuki Koga, Takahiro Maeda, Kikuko Amo-Shiinoki, Hiroyuki Ochi, Yui Ichiki, Shogo Fukuyama, Saori Suzuki, Natsuki Suizu, Takaaki Ohmine, Sakurako Hamachi, Hiroshi Tsuneki, Shigeru Okuya, Toshiyasu Sasaoka, Yukio Tanizawa, Fumihiro Nagashima
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Hachimijiogan (HJG) has originally been used to ameliorate a variety of symptoms associated with low ambient temperatures. However, its pharmacological action in metabolic organs remains unclear. We hypothesized that HJG may modulate metabolic functi
Externí odkaz:
https://doaj.org/article/6a843b8816024421a6964c11f6afff37
Publikováno v:
Pharmacologytherapeutics. 235
Bamboo is a medicinal plant, and has long been used as a traditional/folk medicine and a food preservative in Japan. Bamboo leaf contains many active ingredients with medicinal benefits. In particular, recent studies demonstrated that bamboo leaf ext
Publikováno v:
Traditional & Kampo Medicine. 4:58-61
Cases A sudden asthma attack in patient 1, a 36-year-old man, was treated with standard anti-asthma drugs; and patient 2, a 76-year-old woman, developed asthma 6 years earlier that worsened every winter. Standard anti-asthma drugs inadequately improv
Autor:
Yuki Kishida, Hideki Yoshikawa, Shizue Otsuka, Keisuke Hagihara, Junsuke Arimitsu, Miho Nakanishi, Noriko Sakashita, Syota Kagawa
Publikováno v:
Phytomedicine. 22(1):16-22
Sarcopenia is characterized by age-associated skeletal muscle atrophy and reduced muscle strength; currently, no pharmaceutical treatment is available. Go-sha-jinki-Gan (GJG) is a traditional Japanese herbal medicine that is used to alleviate various
Autor:
Norihiko Mori, Yoshiyuki Soeda, Naoki Toyooka, Xu Wang, Shuji Hosoh, Syota Kagawa, Hiroshi Tsuneki, Toshiyasu Sasaoka, Teruko Uwano, Hayato Muranaka, Yoshinori Ichihara, Yusaku Takamura, Tsutomu Wada, Hisao Nishijo
Publikováno v:
Molecular Endocrinology. 24:1965-1977
Impairment of insulin and IGF-I signaling in the brain is one of the causes of dementia associated with diabetes mellitus and Alzheimer’s disease. However, the precise pathological processes are largely unknown. In the present study, we found that
Publikováno v:
Journal of Neurochemistry. 110:791-800
Indoleamine 2,3-dioxygenase (IDO) is the rate-limiting enzyme of the kynurenine pathway of tryptophan metabolism, ultimately leading to production of the excitotoxin quinolinic acid (QUIN) by monocytic cells. In the Tg2576 mouse model of Alzheimer's
Autor:
Saori Yaguchi, Syota Kagawa, Takeshi Oya, Hajime Ishihara, Toshiyasu Sasaoka, Hiroshi Tsuneki, Masakiyo Sasahara, Yoshiyuki Soeda, Ryo Oshita, Tsutomu Wada
Publikováno v:
Endocrinology. 149:642-650
SH2-containing inositol 5'-phosphatase 2 (SHIP2) is a 5'-lipid phosphatase hydrolyzing the phosphatidylinositol (PI) 3-kinase product PI(3,4,5)P(3) to PI(3,4)P(2) in the regulation of insulin signaling, and is shown to be increased in peripheral tiss
Autor:
Tsutomu Wada, Hajime Ishihara, Syota Kagawa, Kiyofumi Nagira, Mariko Ikubo, Kazuhito Fukui, Toshiyasu Sasaoka, Masashi Kobayashi
Publikováno v:
Diabetes. 54:1958-1967
We investigated the role of hepatic SH2-containing inositol 5′-phosphatase 2 (SHIP2) in glucose metabolism in mice. Adenoviral vectors encoding wild-type SHIP2 (WT-SHIP2) and a dominant-negative SHIP2 (ΔIP-SHIP2) were injected via the tail vein in
Autor:
Yuji Takei, Akiyo Yamada, Syota Kagawa, Yasushi Saga, Shizuo Machida, Hiroyuki Fujiwara, Hiroaki Nonaka, Osamu Takikawa, Mitsuaki Suzuki, Hidetoshi Akimoto
Publikováno v:
International Journal of Oncology. 38
The purpose of this study was to clarify the relationship between ovarian cancer peritoneal dissemination and indoleamine 2,3-dioxygenase (IDO) expression, and to explore the possibility of IDO-targeting molecular therapy for ovarian cancer. We trans